即日起,下列任一Elisa试剂盒只要¥2800,任两组¥4800,售完为止。
Human *标星号者为独特优势产品
|
Target name |
Catalog no. |
Sensitivity |
Target name |
Catalog no. |
Sensitivity |
|
Adiponectin |
0.08 ng/ml |
IL22 |
8 pg/ml |
||
|
apoA1 |
1.5 ng/ml |
IL23 |
8 pg/ml |
||
|
BAFF |
30 pg/ml |
IL27 |
30 pg/ml |
||
|
*BD-1 / beta Defensin-1 |
4pg/ml |
IL29 / IFN lambda |
15 pg/ml |
||
|
*BD-2 / beta Defensin-2 |
4 pg/ml |
IL2sR alpha |
15 pg/ml |
||
|
*BD-4 / beta Defensin-4 |
0.8pg/ml |
IL3 |
15 pg/ml |
||
|
beta NGF |
4 pg/ml |
IL31 |
30 pg/ml |
||
|
Betacellulin / BTC |
15pg/ml |
IL33 |
8 pg/ml |
||
|
bFGF |
60 pg/ml |
IL37/IL1F7 / FIL1 zeta |
15 pg/ml |
||
|
BMP2 |
30 pg/ml |
IL4 |
8 pg/ml |
||
|
CRP |
0.4 ng/ml |
IL5 |
8 pg/ml |
||
|
CTACK / CCL27 |
8 pg/ml |
IL6 |
4 pg/ml |
||
|
CXCL10 / IP10 |
2 pg/ml |
IL7 |
8 pg/ml |
||
|
CXCL12 / SDF-1 |
60 pg/ml |
IL8 |
4 pg/ml |
||
|
CXCL16 |
8 pg/ml |
IL9 |
24 pg/ml |
||
|
CXCL4 / PF4 |
30 pg/ml |
Leptin |
8 pg/ml |
||
|
EGF |
8 pg/ml |
MCP-1 / CCL2 |
8 pg/ml |
||
|
FGF21 |
15 pg/ml |
MCP2 / CCL8 |
0.8 pg/ml |
||
|
G-CSF |
15 pg/ml |
MIG / CXCL9 |
8 pg/ml |
||
|
GM-CSF |
8 pg/ml |
MIP1 alpha / CCL3 |
15 pg/ml |
||
|
Granzyme B |
8 pg/ml |
MIP1 beta |
2 pg/ml |
||
|
*GRO beta / CXCL2 |
0.8 pg/ml |
MMP1 (Total) |
40 pg/ml |
||
|
Heregulin beta1 |
30 pg/ml |
MMP9 |
15 pg/ml |
||
|
HGF |
60 pg/ml |
*Neuroserpin |
30 pg/ml |
||
|
IFN alpha |
6 pg/ml |
PDGF-BB |
30 pg/ml |
||
|
IFN gamma |
8 pg/ml |
*Perforin |
20 pg/ml |
||
|
IgE |
0.2 ng/ml |
*PIGF1 |
15 pg/ml |
||
|
IGF-BP1 |
25 pg/ml |
RANTES |
8 pg/ml |
||
|
IgG (Total) |
0.8 ng/ml |
*RELM beta |
4 pg/ml |
||
|
IgM |
0.16 ng/ml |
Resistin |
8 pg/ml |
||
|
IL1 alpha |
30 pg/ml |
sCD40L |
30 pg/ml |
||
|
IL1 beta |
4 pg/ml |
SCF |
15 pg/ml |
||
|
IL10 |
1 pg/ml |
sICAM1 |
0.2 ng/ml |
||
|
IL11 |
15 pg/ml |
sRANK Ligand |
15 pg/ml |
||
|
IL12 / 23 P40 |
8 pg/ml |
TGF alpha |
2 pg/ml |
||
|
IL12 p70 |
8 pg/ml |
TGF beta1 |
15 pg/ml |
||
|
IL13 |
15 pg/ml |
Thrombopoietin (Tpo) |
30 pg/ml |
||
|
IL15 |
8 pg/ml |
TIMP1 |
15 pg/ml |
||
|
IL17 / IL17A |
8 pg/ml |
TIMP4 |
30 pg/ml |
||
|
*IL17E |
15 pg/ml |
*TL1A |
15 pg/ml |
||
|
IL18 |
8 pg/ml |
TNF alpha |
8 pg/ml |
||
|
IL1RA |
50 pg/ml |
TWEAK |
15 pg/ml |
||
|
IL2 |
8 pg/ml |
VCAM1 |
15 pg/ml |
||
|
IL21 |
24 pg/ml |
VEGF |
8 pg/ml |
Mouse
|
Target name |
Catalog no. |
Sensitivity |
Target name |
Catalog no. |
Sensitivity |
|
CCL21 / Exodus2 |
63 pg/ml |
IL22 |
24 pg/ml |
||
|
Cxcl1 |
8 pg/ml |
IL23 |
30 pg/ml |
||
|
CXCL10 / IP10 |
4 pg/ml |
IL27 |
15 pg/ml |
||
|
GM-CSF |
4 pg/ml |
IL33 |
24 pg/ml |
||
|
IFN gamma |
8 pg/ml |
IL33R / ST2 |
0.08 ng/ml |
||
|
IGF1 |
50 pg/ml |
IL4 |
8 pg/ml |
||
|
IgG (Total) |
1 ng/ml |
IL-5 |
8pg/ml |
||
|
IgM |
0.16 ng/ml |
IL6 |
8 pg/ml |
||
|
IL1 alpha |
15 pg/ml |
MCP1 / CCL2 |
15 pg/ml |
||
|
IL1 beta |
8 pg/ml |
MDC |
2 pg/ml |
||
|
IL10 |
15 pg/ml |
MIP1 alpha / CCL3 |
1.6 pg/ml |
||
|
IL12 / IL23 p40 |
8 pg/ml |
MIP2 / CXCL2 |
4 pg/ml |
||
|
IL12 p70 |
8 pg/ml |
Mouse IgE |
0.8 ng/ml |
||
|
IL13 |
8 pg/ml |
RANTES |
4 pg/ml |
||
|
IL15 |
12 pg/ml |
sRANK Ligand |
15 pg/ml |
||
|
IL17 / IL17A |
8 pg/ml |
TGF beta1 |
15 pg/ml |
||
|
IL17E |
30 pg/ml |
TNF alpha |
8 pg/ml |
||
|
IL2 |
8 pg/ml |
VEGF |
8 pg/ml |
||
|
IL21 |
50 pg/ml |
|
|||
|
Target name |
Catalog no. |
Sensitivity |
Target name |
Catalog no. |
Sensitivity |
|
CNTF |
15 pg/ml |
IL2 |
15 pg/ml |
||
|
CXCL1 / CINC1 |
2 pg/ml |
IL4 |
30 pg/ml |
||
|
EGF |
2 pg/ml |
IL6 |
30 pg/ml |
||
|
IFN gamma |
8 pg/ml |
MCP1 / CCL2 |
15 pg/ml |
||
|
*IgE |
4 ng/ml |
*MIP-1 alpha |
2 pg/ml |
||
|
IgG1 |
4 ng/ml |
*RANTES |
2 pg/ml |
||
|
IL1 alpha |
4 pg/ml |
*SCF |
15 pg/ml |
||
|
IL1 beta |
30 pg/ml |
TGF beta1 |
15 pg/ml |
||
|
IL10 |
30 pg/ml |
TNF alpha |
30 pg/ml |
||
|
IL17 / IL17A |
8 pg/ml |
VEGF |
8 pg/ml |
http://arigobio.biomart.cn/news/2787455.htm
| 序号 | 最新资讯 | 浏览次数 | 作者 | 发布时间 |
| 1 | 兔子单克隆抗体制备 | 2042 | 市场部 | 2021-11-04 |
| 2 | 技术服务|生物偶联服务 | 1808 | 市场部 | 2021-11-03 |
| 3 | 技术服务|哺乳动物细胞蛋白表达系统 | 2806 | 市场部 | 2021-10-27 |
| 4 | 技术服务|热稳定性scFV/Fab筛选 | 2231 | 市场部 | 2021-10-26 |
| 5 | 技术服务|抗体&蛋白纯化服务 | 989 | 市场部 | 2021-10-20 |
| 6 | 技术服务|全人源单抗制备 | 994 | 市场部 | 2021-10-15 |